ARCT - Arcturus Therapeutics Holdings Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 27.27

Open

$ 27.82

Bid

$ 27.23 x 200

Ask

$ 27.27 x 200

Day's Range

$ 26.80 - $ 28.27

52 Week Range

$ 17.52 - $ 43.81

Volume

671,641

Average Volume

Market Cap

726.15M

Beta (5Y Monthly)

$ 1.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-14-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-07-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-29-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	03-01-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	03-01-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	03-16-2020	12-31-2019	10-K
18	11-08-2019	09-30-2019	10-Q
19	08-14-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Arct...
03/20/2024 10:44:28

HC Wainwright & Co. reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price target.

The Analyst Verdict: Arcturus Therapeutics...
03/11/2024 12:01:29

Canaccord Genuity Maintains Buy on Arcturu...
03/11/2024 11:51:35

Canaccord Genuity analyst Whitney Ijem maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target ...

HC Wainwright & Co. Reiterates Buy on Arct...
03/08/2024 14:42:42

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price ta...

Recap: Arcturus Therapeutics Q4 Earnings
03/07/2024 21:05:07

Arcturus Therapeutics Q4 2023 GAAP EPS $(0...
03/07/2024 21:03:49

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.320) per share which beat the analyst consensus estimate o...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

Earnings Preview: Arcturus Therapeutics
03/06/2024 15:01:58

Arcturus Therapeutics Receives Orphan Medi...
02/22/2024 13:33:35

Citigroup Maintains Buy on Arcturus Therap...
02/08/2024 16:04:52

Citigroup analyst Yigal Nochomovitz maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target fro...

Arcturus Therapeutics Announces New COVID-...
02/05/2024 13:31:59

Short communication follows previously published data in The Lancet Infectious Diseases demonstrating Immunological Non-Inferio...

logitech-posts-q3-results-joins-coinbase-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Logitech Posts Q3 Results, Joins Coinbase ...
01/23/2024 10:04:19

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

CSL And Arcturus Therapeutics Announced Th...
12/21/2023 13:14:31

Data follow approval of the world's first Self-Amplifying messenger RNA (sa-mRNA) COVID-19 Vaccine for Adults by Japan Mini...

arcturus-therapeutics-lung-disease-candidate-triggers-bullish-rating-analyst-sees-over-200-upside

Arcturus Therapeutics' Lung Disease Candid...
12/13/2023 18:34:47

Canaccord Genuity has initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT), a player in the genetic medicine...

Canaccord Genuity Initiates Coverage On Ar...
12/13/2023 09:35:31

Canaccord Genuity analyst Whitney Ijem initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating.

5 Value Stocks In The Healthcare Sector
12/04/2023 14:44:10

Japan's Ministry Of Health, Labour And Wel...
11/28/2023 13:08:17

HC Wainwright & Co. Reiterates Buy on Arct...
11/28/2023 12:22:39

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $51 price ta...

Arcturus Therapeutics Receives Orphan Drug...
11/27/2023 13:32:54

First cystic fibrosis patient in Phase 1b study successfully completed two administrations of ARCT-032On track to share interim...

why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Shapeways Holdings Shares Are Trading ...
11/15/2023 19:04:31

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.